ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Cancer Therapeutics Research Group

Include trials that are no longer recruiting patients.

3 studies were found.
1.Recruiting3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer
2.RecruitingFenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
Conditions: recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
3.RecruitingIrofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
Conditions: recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act